Structure Info
- Chemspace ID
- CSSS00103152045 (In-Stock Screening Compounds)
- CAS
- 781613-23-8
- MFCD
- MFCD28501234, MFCD23726660, MFCD22124889
- IUPAC Name
- 7-{[(3aR,5R,6aS)-2-methyl-octahydrocyclopenta[c]pyrrol-5-yl]methoxy}-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine
- Mol formula
- C24H25Cl2FN4O2
- Mol weight
- 491 Da
- Catalog Number(s)
- 27049, 169474, A100327, AA00G3NR, AG00G3QJ, AH51139, AOS00G3QJ, AR00G4FJ, AS-55834, BB4LS-BD335357, BD335357, CD31000807, CSC103152045, F979840, HY-13314, TQ0166, X746318
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 5.25
- Heavy atoms count
- 33
- Rotatable bond count
- 6
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 0.416
- Polar surface area (Å)
- 60
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSS00103152045
Items Overall 14 items from 3 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 10 days | United States To: | 99 | 1 mg | 142 | |
MedChemExpress | 10 days | United States To: | 99 | 5 mg | 300 | |
MedChemExpress | 10 days | United States To: | 99 | 10 mg | 580 | |
MedChemExpress | 10 days | United States To: | 99 | 10mM/1mL | 324 | |
Description: Names: Tesevatinib; XL-647; EXEL-7647; KD-019; Product Description: Tesevatinib (XL-647) is an orally available, blood-brain barrier-penetrant inhibitor of the epidermal growth factor receptor ( EGFR ). Tesevatinib significantly reduces cellular viability, with IC 50 values of 11 nM and 102 nM in GBM12 and GBM6, respectively. Tesevatinib also inhibits HER2 ( IC 50 =16.1 nM), VEGFR2 ( IC 50 =1.5 nM), and Src ( IC 50 =10.3 nM). Tesevatinib can inhibit tumor proliferation and exhibits antitumor activity .; Target: EGFR;Src;VEGFR; CAS: 781613-23-8 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 99 | 1 mg | 150 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 316 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 611 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 342 | |
Description: Names: Tesevatinib; XL-647; EXEL-7647; KD-019; Product Description: Tesevatinib (XL-647) is an orally available, blood-brain barrier-penetrant inhibitor of the epidermal growth factor receptor (EGFR). Tesevatinib significantly reduces cellular viability, with IC50 values of 11 nM and 102 nM in GBM12 and GBM6, respectively. Tesevatinib also inhibits HER2 (IC50=16.1 nM), VEGFR2 (IC50=1.5 nM), and Src (IC50=10.3 nM). Tesevatinib can inhibit tumor proliferation and exhibits antitumor activity; Target: EGFR;Src;VEGFR; CAS: 781613-23-8 | ||||||
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 1 mg | 109 | |
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 2 mg | 158 | |
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 5 mg | 249 | |
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 10 mg | 482 | |
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 25 mg | 789 | |
Targetmol Chemicals Inc | 30 days | United States To: | 98 | 50 mg | 1,080 | |
Description: Tesevatinib (XL-647) is an oral, multi-targeted tyrosine kinase inhibitor with IC50 values of 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR, ErbB2, KDR, Flt4, and EphB4.; CAS: 781613-23-8 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire